Old Web
English
Sign In
Acemap
>
authorDetail
>
Jacqueline Coblentz
Jacqueline Coblentz
McGill University Health Centre
Melanoma
Anatomy
Ceritinib
ALK inhibitor
Crizotinib
4
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Proteomic Characterization of Extracellular Vesicles in Rabbit Model of Uveal Melanoma
2021
Investigative Ophthalmology & Visual Science
Alexander Laskaris
Prisca Bustamante
Thupten Tsering
Christina Mastromonaco
Jacqueline Coblentz
Julia V. Burnier
Show All
Source
Cite
Save
Citations (0)
Ocular findings in patients undergoing cancer treatment
2021
Investigative Ophthalmology & Visual Science
Jacqueline Coblentz
Christina Mastromonaco
Sabrina Bergeron
Georges Nassrallah
Ana Beatriz Toledo Dias
Anelise Savaris Dias
Miguel N. Burnier
Show All
Source
Cite
Save
Citations (0)
Circulating tumor DNA tracking through driver mutations as a liquid biopsy-based biomarker for uveal melanoma.
2021
Journal of Experimental & Clinical Cancer Research
Prisca Bustamante
Thupten Tsering
Jacqueline Coblentz
Christina Mastromonaco
Mohamed Abdouh
Cristina Fonseca
Rita Pinto Proença
Nadya Blanchard
Claude Laure Dugé
Rafaella Atherino Schmidt Andujar
Emma Youhnovska
Miguel N. Burnier
S.A. Callejo
Julia V. Burnier
Show All
Source
Cite
Save
Citations (2)
Ceritinib is a more potent ALK inhibitor than crizotinib in uveal melanoma
2018
Investigative Ophthalmology & Visual Science
Jade Marie Lasiste
Christina Mastromonaco
Prisca Raquel Bustamante
Jacqueline Coblentz
Laura Nuñez
Patrick T Logan
Miguel N. Burnier
Show All
Source
Cite
Save
Citations (0)
1